Owner Yale University

Inventors WAXMAN, Stephen; DIB-HAJJ, Sulyman

Agent FB Rice

Pub. Number AU-B-2003257922

Parent 764376

Filing date 29 October 2003

Wipo publication date 20 November 2003

Acceptance publication date 10 January 2008

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

G01N 33/84 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving inorganic compounds or pH